StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance The company has a market cap of $726,000.00, a price-to-earnings ratio of -0.02 and a beta of 1.63. The stock has […]
StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance Shares of NASDAQ INFI opened at $0.01 on Friday. The firm has a market cap of $726,080.00, a P/E ratio of […]